symbol,statement_type,period_end,line_item,value
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-1308929000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,0.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-1501080000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,End Cash Position,211068000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,36009000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,175059000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,252217000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-31134000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,0.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,0.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,283351000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,285558000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Issuance,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-2207000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-269309000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,187386000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,1044385000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of Business,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-1501080000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-1501080000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,192151000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-9374000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-1085329000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,62158000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-67823000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-621454000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-490660000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-27374000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,-69716000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,345458000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation,345458000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-58488000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,3198000.0
ORCHPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,994633000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,611772000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-2085472000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,0.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,3919421000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-648148000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,End Cash Position,36009000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,225971000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-189962000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,1670404000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-48964000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,3919421000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,3919421000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-2200053000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,0.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Issuance,
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-2200053000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-2085472000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,0.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-3120286000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,120017000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-2592155000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,0.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of Business,
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,0.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-648148000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,0.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-648148000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,1259920000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,6287000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-78378000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-395840000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Payable,548513000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-354881000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,196467000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,64000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,-2651000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,332371000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,11306000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation,332371000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,76264000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,1884000.0
ORCHPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,890474000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-665751000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-1098063000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,1731984000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,0.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-849131000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,End Cash Position,225971000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,43066000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,182905000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,311664000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-322257000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,0.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,0.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,633921000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,1731984000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Issuance,1731984000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,633921000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-1098063000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,1731984000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-312139000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,4610000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-53073000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-53073000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Business Purchase And Sale,0.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of Business,576100000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Business,0.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-263676000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,585455000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-849131000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,183380000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-2985000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-790621000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,105684000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Payable,139141000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-560817000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-416535000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,316077000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,11883000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,547868000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,78000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation,547790000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-154000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,16444000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-399850000.0
ORCHPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,463183000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,780711000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-2047852000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,199988000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,0.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-144035000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,End Cash Position,43066000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,156939000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-113873000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-2167981000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-320117000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,0.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,0.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-1847864000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,199988000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Issuance,199988000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-1847864000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-2047852000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,199988000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,1129362000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,4881000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,128446000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,128446000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Business Purchase And Sale,-455000000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of Business,1594081000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Business,-455000000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,1451035000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,1595070000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-144035000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,924746000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-19060000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,595657000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,260752000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Payable,473627000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,25369000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-229194000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,315929000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,36673000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,870246000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,313000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation,869933000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-891810000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,1400000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-4000.0
ORCHPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,-19512000.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,-1250800000.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,0.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Issuance,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,-1250800000.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,0.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Business Purchase And Sale,0.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of Business,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Business,0.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,2864000.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,-19418000.0
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
ORCHPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
